Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trialJacob Elkins, Mitchell S.V. Elkind, Aneesh B. Singhal et al.|The Lancet Neurology|2017Cited by 213
Functional Status Predicts Acute Care Readmissions from Inpatient Rehabilitation in the Stroke PopulationChloe Slocum, Jeffrey C Schneider, Paul Gerrard et al.|PLoS ONE|2015Cited by 46